- Home
- IGC vs ABVC Comparison
IGC vs ABVC Comparison
Compare IGC & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IGC | ABVC |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.0M | 34.6M |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | IGC | ABVC |
|---|---|---|
| Price | $0.29 | $1.06 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $5.25 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 108.2K |
| Earning Date | 03-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | 7.14 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,271,000.00 | $509,589.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $0.71 |
| 52 Week High | $0.45 | $3.39 |
Technical Indicators
Market Signals| Indicator | IGC | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 51.04 | 58.87 |
| Support Level | $0.28 | $0.96 |
| Resistance Level | $0.31 | $1.14 |
| Average True Range (ATR) | 0.01 | 0.08 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 26.32 | 97.32 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.